These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2575471)

  • 1. CR1 polymorphism in hydralazine-induced systemic lupus erythematosus: DNA restriction fragment length polymorphism.
    Mitchell JA; Sim RB; Sim E
    Clin Exp Immunol; 1989 Dec; 78(3):354-8. PubMed ID: 2575471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte complement receptor type 1 (CR1) expression and circulating immune complex (CIC) levels in hydralazine-induced SLE.
    Mitchell JA; Batchelor JR; Chapel H; Spiers CN; Sim E
    Clin Exp Immunol; 1987 May; 68(2):446-56. PubMed ID: 2958187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR1 gene.
    Wilson JG; Wong WW; Murphy EE; Schur PH; Fearon DT
    J Immunol; 1987 Apr; 138(8):2708-10. PubMed ID: 2881967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Size polymorphism of the erythrocyte complement receptor type 1 (CR1) in systemic lupus erythematosus induced by hydralazine.
    Mitchell JA; Sim E
    Complement Inflamm; 1989; 6(2):88-93. PubMed ID: 2721176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hind III genomic polymorphism of the C3b receptor (CR1) in patients with SLE: low erythrocyte CR1 expression is an acquired phenomenon.
    Kumar A; Kumar A; Sinha S; Khandekar PS; Banerjee K; Srivastava LM
    Immunol Cell Biol; 1995 Oct; 73(5):457-62. PubMed ID: 8595925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inherited deficiency of erythrocyte complement receptor type 1 does not cause susceptibility to systemic lupus erythematosus.
    Moldenhauer F; David J; Fielder AH; Lachmann PJ; Walport MJ
    Arthritis Rheum; 1987 Sep; 30(9):961-6. PubMed ID: 2959289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of the HindIII restriction fragment length polymorphism among patients with systemic lupus erythematosus with different concentrations of CR1.
    Satoh H; Yokota E; Tokiyama K; Kawaguchi T; Niho Y
    Ann Rheum Dis; 1991 Nov; 50(11):765-8. PubMed ID: 1685310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The frequency of complement receptor type 1 (CR1) gene polymorphisms in nine families with multiple cases of systemic lupus erythematosus.
    Tebib JG; Martinez C; Granados J; Alarcon-Segovia D; Schur PH
    Arthritis Rheum; 1989 Nov; 32(11):1465-9. PubMed ID: 2573360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CR1 density polymorphism and expression on erythrocytes of patients with systemic lupus erythematosus.
    Kiss E; Csipö I; Cohen JH; Reveil B; Kávai M; Szegedi G
    Autoimmunity; 1996; 25(1):53-8. PubMed ID: 9161700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis of CR1 expression on erythrocytes of patients with systemic lupus erythematosus.
    Cohen JH; Caudwell V; Levi-Strauss M; Bourgeois P; Kazatchkine MD
    Arthritis Rheum; 1989 Apr; 32(4):393-7. PubMed ID: 2565113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: no correlation with structural or numerical polymorphisms.
    Moldenhauer F; Botto M; Walport MJ
    Clin Exp Immunol; 1988 Apr; 72(1):74-8. PubMed ID: 2899464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte complement receptor type 1 in patients with systemic lupus erythematosus.
    Yen JH; Liu HW; Lin SF; Chen JR; Chen TP
    J Rheumatol; 1989 Oct; 16(10):1320-5. PubMed ID: 2810256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus.
    Arora V; Verma J; Dutta R; Marwah V; Kumar A; Das N
    Mol Immunol; 2004 Jun; 41(4):449-56. PubMed ID: 15163541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of leukocyte CR1 gene transcription with the disease severity and renal involvement in systemic lupus erythematosus.
    Verma J; Arora V; Marwaha V; Kumar A; Das N
    Lupus; 2005; 14(4):273-9. PubMed ID: 15864913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased C3b receptors (CR1) on erythrocytes from patients with systemic lupus erythematosus.
    Holme E; Fyfe A; Zoma A; Veitch J; Hunter J; Whaley K
    Clin Exp Immunol; 1986 Jan; 63(1):41-8. PubMed ID: 2937582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
    Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
    J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune complex binding to erythrocyte-CR1 (CD 35), CR1 expression and levels of erythrocyte-fixed C3 fragments in SLE outpatients.
    Jepsen HH; Møller Rasmussen J; Teisner B; Schrøder L; Holmskov U; Jarlbaek L; Isager H; Svehag SE
    APMIS; 1990 Jul; 98(7):637-44. PubMed ID: 2144431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy.
    Corvetta A; Pomponio G; Bencivenga R; Luchetti MM; Spycher M; Spaeth PJ; Danieli G
    J Rheumatol; 1991 Jul; 18(7):1021-5. PubMed ID: 1833542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
    J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural polymorphisms of complement receptor 1 (CR1) in systemic lupus erythematosus (SLE) patients and normal controls of three ethnic groups.
    Moulds JM; Reveille JD; Arnett FC
    Clin Exp Immunol; 1996 Aug; 105(2):302-5. PubMed ID: 8706338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.